HCPCS code J9349 — Inj., tafasitamab-cxix. Status: Active. Effective Apr 1, 2021. Source: CMS HCPCS Level II.

J9349

Active

Inj., tafasitamab-cxix

Injection, tafasitamab-cxix, 2 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Apr 1, 2021
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9385

MUE — Medically Unlikely Edits

Maximum units of J9349 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 900
Practitioner Services 900

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
50881-0013-03 Monjuvi
73535-0208-01 Monjuvi

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2021-Q2
    Inj., tafasitamab-cxix